There have also been promising results in murine studies regarding the therapeutic potential of BAFF/APRIL inhibitors in treating SLE, however, clinical trials of anti-BAFF antibodies have failed to show significant results so far 77, 78, 83. The gene discussed is TNFSF13; the disease is systemic lupus erythematosus.